Lpath Inc. a therapeutic antibody company, was awarded a $3 million grant by the National Eye Institute.
Volcano Corp. (Nasdaq: VOLC) said Friday it turned a profit in the second quarter as sales of products used in vascular testing increased.
Obese patients who took Orexigen Therapeutics Inc.'s experimental pill combining an anti-addiction drug and an antidepressant lost more weight than those who took a placebo, a company-sponsored study found.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focusing on treatments for central nervous system disorders, announced that it has initiated a new Phase 3 trial of pimavanserin as a treatment for Parkinson’s disease psychosis (PDP).
Camille Sobrian has been promoted to president of Connect, the organization announced Thursday.
Diagnostic test maker Gen-Probe Inc. (Nasdaq: GPRO) said Thursday its second-quarter net income jumped 42 percent on higher revenue from blood screening and women's health products.
Shares of Life Technologies Corp. (Nasdaq: LIFE) dropped by nearly 6 percent in midday trading Thursday after the life sciences and medical research tools company said its second-quarter net income surged on a boost in sales.
Cytori Therapeutics (Nasdaq: CYTX) has received European (CE Mark) approval for the PureGraft 250/PURE System for autologous fat grafting procedures, allowing Cytori to commercialize the product line to physicians in Europe.
AMN Healthcare Services Inc., a specialist in temporary jobs for nurses, said it will amend its revolving credit facility to finance the acquisition of Medfinders Inc.
Illumina Inc. (Nasdaq: ILMN) said Tuesday in its second-quarter earnings report that it acquired Carlsbad-based Helixis in April for $105 million.
